Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation

2014/12/04 by Gordon I. Smith, Jun Yoshino, Kelly L. Stromsdorfer +6 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Muscle metabolism and nutrition #Adipose Tissue and Metabolism #Metabolism, Diabetes, and Cancer

paper · pdf · doi:10.2337/db14-1279

Abstract

Increased plasma branched-chain amino acid concentrations are associated with insulin resistance, and intravenous amino acid infusion blunts insulin-mediated glucose disposal. We tested the hypothesis that protein ingestion impairs insulin-mediated glucose disposal by leucine-mediated mTOR signaling, which can inhibit AKT. We measured glucose disposal and muscle p-mTOR(Ser2448), p-AKT(Ser473), and p-AKT(Thr308) in 22 women during a hyperinsulinemic-euglycemic clamp procedure with and without concomitant ingestion of whey protein (0.6 g/kg fat-free mass; n = 11) or leucine that matched the amount given with whey protein (n = 11). Both whey protein and leucine ingestion raised plasma leucine concentration by approximately twofold and muscle p-mTOR(Ser2448) by ∼30% above the values observed in the control (no amino acid ingestion) studies; p-AKT(Ser473) and p-AKT(Thr308) were not affected by whey protein or leucine ingestion. Whey protein ingestion decreased insulin-mediated glucose disposal (median 38.8 [quartiles 30.8, 61.8] vs. 51.9 [41.0, 77.3] µmol glucose/µU insulin · mL(-1) · min(-1); P < 0.01), whereas ingestion of leucine did not (52.3 [43.3, 65.4] vs. 52.3 [43.9, 73.2]). These results indicate that 1) protein ingestion causes insulin resistance and could be an important regulator of postprandial glucose homeostasis and 2) the insulin-desensitizing effect of protein ingestion is not due to inhibition of AKT by leucine-mediated mTOR signaling.

Cited by

• Postprandial Blood Glucose-Focused Dietary Approaches and Their Limitations
• Co-Ingestion of Whey Protein with a Carbohydrate-Rich Breakfast Does Not Affect Glycemia, Insulinemia or Subjective Appetite Following a Subsequent Meal in Healthy Males. [europepmc]
• High-Protein Intake during Weight Loss Therapy Eliminates the Weight-Loss-Induced Improvement in Insulin Action in Obese Postmenopausal Women. [europepmc]
• Metabolic Inflexibility Is an Early Marker of Bed-Rest-Induced Glucose Intolerance Even When Fat Mass Is Stable. [europepmc]
• Total energy intake according to the level of skeletal muscle mass in Korean adults aged 30 years and older: an analysis of the Korean National Health and Nutrition Examination Surveys (KNHANES) 2008-2011. [europepmc]
• Lower Fasted-State but Greater Increase in Muscle Protein Synthesis in Response to Elevated Plasma Amino Acids in Obesity. [europepmc]
• Metabolites as regulators of insulin sensitivity and metabolism. [europepmc]
• Postprandial Glycaemic, Hormonal and Satiety Responses to Rice and Kiwifruit Preloads in Chinese Adults: A Randomised Controlled Crossover Trial. [europepmc]
• Protectiveness of Artesunate Given Prior Ischemic Cerebral Infarction Is Mediated by Increased Autophagy. [europepmc]
• SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice. [europepmc]
• Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. [europepmc]
• A Short-Term Feeding of Dietary Casein Increases Abundance of Lactococcus lactis and Upregulates Gene Expression Involving Obesity Prevention in Cecum of Young Rats Compared With Dietary Chicken Protein. [europepmc]
• Differential regulation of mTORC1 activation by leucine and β-hydroxy-β-methylbutyrate in skeletal muscle of neonatal pigs. [europepmc]
• Whey for Sarcopenia; Can Whey Peptides, Hydrolysates or Proteins Play a Beneficial Role? [europepmc]
• Whey protein consumption following fasted exercise reduces early postprandial glycaemia in centrally obese males: a randomised controlled trial. [europepmc]
• Dietary protein intake and obesity-associated cardiometabolic function. [europepmc]
• The Clinical Application of Mealtime Whey Protein for the Treatment of Postprandial Hyperglycaemia for People With Type 2 Diabetes: A Long Whey to Go. [europepmc]
• A Novel Dietary Intervention Reduces Circulatory Branched-Chain Amino Acids by 50%: A Pilot Study of Relevance for Obesity and Diabetes. [europepmc]
• Current progress in metabolomics of gestational diabetes mellitus. [europepmc]
• High Protein Diet Feeding Aggravates Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides. [europepmc]
• Maternal and Fetal Metabolites in Gestational Diabetes Mellitus: A Narrative Review. [europepmc]
• Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ. [europepmc]
• Effects of Branched-Chain Amino Acids on Skeletal Muscle, Glycemic Control, and Neuropsychological Performance in Elderly Persons with Type 2 Diabetes Mellitus: An Exploratory Randomized Controlled Trial. [europepmc]
• Branched-Chain Amino Acids and Insulin Resistance, from Protein Supply to Diet-Induced Obesity. [europepmc]
• Uncoupling hepatic insulin resistance - hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes. [europepmc]
• Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk. [europepmc]

Related

• Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes
• Plasma metabolomics of an oral protein tolerance test reveals altered amino acid handling in sarcopenia
• Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
• Effects of leucine and its metabolite β‐hydroxy‐β‐methylbutyrate on human skeletal muscle protein metabolism
• Insulin resistance: Review of the underlying molecular mechanisms